Patent · US Active

Pharmaceutical compositions with enhanced permeation

US11273131B2 · kind B2 · utility

0Cited by

455References

58Claims

0Family size

Assignee

Aquestive Therapeutics, Inc. · US

Inventors

Alexander Mark Schobel · Whitehouse Station, US
Stephanie Marie Varjan · Oradell, US
Stephen Paul Wargacki · Pittstown, US

Key dates

Filing date	Oct 3, 2017
Grant date	Mar 15, 2022
Priority date	—
Expiry date	Nov 17, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M2037/0023
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical compositions having enhanced active component permeation properties are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.